Expression of myosin light chain kinase in kidney of streptozotocin-induced diabetic rats

International Journal of Molecular Sciences

Volumn 7, Issue 11, 2006, Pages 510-518

  Zhu, Huaqing ^a   Zhang, Xiaolin ^a   Zuo, Li ^a   Zhou, Qing ^a   Gui, Shuyu ^a   Wei, Wei ^a   Wang, Yuan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes nephropathy; Insulin; Myosin light chain kinase; Rats

Indexed keywords

CARBENOID; ISOPHANE INSULIN; MYOSIN LIGHT CHAIN KINASE; POLYOXYMETHYLENE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; KIDNEY METABOLISM; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

RATTUS;

EID: 33947316887     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/i7110510     Document Type: Article

References (28)

1. Malhotra, A.; Sanghi, V. Regulation of contractile proteins in diabetic heart. Cardiovasc Res. 1997, 34, 34-40.
2. Tsao, T.S.; Stenbit, A.E.; Factor, SM.;Chen, W.; Rossetti, L.; Charron, M.J. Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes.1999, 48, 775-782.
3. Voziyan, P.A.; Metz, T.O.; Baynes, J.W.; Hudson, B.G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem. 2002, 277, 3397-3403.
4. Feliers, D.; Duraisamy, S.; Faulkner, J.L.; Duch, J.; Lee, A.;V.; Abboud, H.E. Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int. 2001, 60, 495-504.
5. Gooch, J.L.; Tang, Y.; Ricono, J.M.; Abboud, H.E. Insulin-like growth factor-I induces renal cell hypertrophy via a calcineurin-dependent mechanism. J Biol Chem. 2001, 276, 42492-42500.
6. Reddy, M.A.; Thimmalapura, P.R.; Lanting, L.; Nadler, J.L.; Fatima, S.; Natarajan, R. The oxidized lipid and lipoxygenase product 12(S)- hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J Biol Chem. 2002, 277, 9920-9928.
7. Natarajan, R.; Gerrity, R.G.; Gu, J.L.; Lanting, L.; Thomas, L.; Nadler, J.L. Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia. 2002, 45, 125-133.
8. Chen, S.; Cohen, M.P.; Lautenslager, G.T.; Shearman, C.W.; Ziyadeh, F.N. Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int. 2001, 59, 673-681.
9. Sun. L.; Pan, X.; Wada, J.; Haas, C.S.; Wuthrich, R.P.; Danesh, F.R. Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy. J Biol Chem. 2002, 277, 29953-29962.
10. Kondo, T.; Kahn, C.R. Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem. 2004, 279, 37997-38006.
11. Yu, P.K.; Yu, D.Y.; Cringle, S.J. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats. Curr Eye Res. 2005, 30, 279-290.
12. Nair, K.S. Aging muscle. Am J Clin Nutr. 2005, 81, 953-963.
13. Isotani, E.; Zhi, G.; Lau, K.S.; Huang, J.; Mizuno, Y.; Persechini, A. Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse. Proc Natl Acad Sci.2004, 101, 6279-6284.
14. Smith, L.; Su, X.; Lin, P.; Zhi, G.; Stull, J.T. Identification of a novel actin binding motif in smooth muscle myosin light chain kinase. J Biol Chem.1999, 274, 29433-29438.
15. Klingenberg, D.; Gunduz, D.; Hartel, F.; Bindewald, K.; Schafer, M.; Piper, H.M. MEK/MAPK as a signaling element in ATP control of endothelial myosin light chain. Am J Physiol Cell Physiol.2004, 286, 807-812.
16. Tran, Q.K.; Watanabe, H.; Le, H.Y.; Pan, L.; Seto, M.; Takeuchi, K. Myosin light chain kinase regulates capacitative ca(2+) entry in human monocytes/macrophages.Arterioscler. Thromb Vasc Biol. 2001, 21, 509-515.
17. Kim, Y.; Chang, S. Modulation of actomyosin contractility by myosin light chain phosphorylation/dephosphorylation through Rho GTPases signaling specifies axon formation in neurons. Biochem Biophys Res Commun. 2004, 318, 579-587.
18. Deng, J.T.; Lierop, J.E.; Sutherland, C.; Walsh, M.P. Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase. J Biol Chem.2001, 276, 16365-16373.
19. Tubman, L.A.; MacIntosh, B.R.; Maki, W.A. Myosin light chain phosphorylation and posttetanic potentiation in fatigued skeletal muscle. Pflugers Arch. 1996, 431, 882-887.
20. Zhou, H.; Murthy, K.S.; Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. Am J Physiol Cell Physiol. 2004, 286, 1130-1138.
21. Wadgaonkar, R.; Nurmukhambetova, S.; Zaiman, A.L.; Garciam, J.G.; Mutation analysis of the non-muscle myosin light chain kinase (MLCK) deletion constructs on CV1 fibroblast contractile activity and proliferation. J Cell Biochem. 2003, 88, 623-634.
22. Goeckeler, Z.M.; Masaracchia, R.A.; Zeng, Q.; Chew, T.L.; Gallagher, P.; Wysolmerski, R.B. Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem. 2000, 275, 18366-18374.
23. Makino, H.; Kashihara, N.; Sugiyama, H.; Kanao, K.; Sekikawa, T.;Okamoto, K.; Maeshima, Y.; Ota, Z.;, Nagai, R. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes, 1996, 45: 488-495.
24. Ichinose, K.; Maeshima, Y.; Yamamoto, Y.; Kitayama, H.; Takazawa, Y.;, Hirokoshi, K. Antiangiogenic endostatin Peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes. 2005, 54, 2891-2903.
25. Adhikary, L.; Chow, F.; Nikolic-Paterson, D.J.; Stambe, C.; Dowling, J.; Atkins, R.C. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia. 2004, 47, 1210-1222.
26. Huang, C.; Jacobson, K.; Schaller, M.D. MAP kinases and cell migration. J Cell Sci. 2004, 117, 4619-4628.
27. Adachi, T.; Stafford, S.; Kayaba, H.; Chihara, J.; Alam, R. Myosin light chain kinase mediates eosinophil chemotaxis in a mitogen-activated protein kinase-dependent manner. J Allergy Clin Immunol.2003, 11, 13-116.
28. Deng, M.; Williams, C.J.; Schultz, R.M. Role of MAP kinase and myosin light chain kinase in chromosome-induced development of mouse egg polarity. Dev Biol. 2005, 278, 358-366.